HIV vaccines: current status worldwide and in Africa.

Fast PE, Kaleebu P.
AIDS 2010; 24 (suppl 4): S50-S60.
PMID: 21042053
Related citation

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S, Mutemwa R, Vallely A, Palanee T, Sookrajh Y, Lacey CJ, Darbyshire J, Grosskurth H, Profy A, Nunn A, Hayes R, Weber J.
Lancet. 2010 Oct 16;376(9749):1329-37. Epub 2010 Sep 17.
PMID: 20851460
Related citation

A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania.

Plummer ML, Watson-Jones D, Lees S, Baisley K, Matari S, Changalucha J, Clayton T, Mugeye K, Tanton C, Weiss HA, Ross DA, HAYES RJ.
AIDS Care 2010; 22: 499-508.
PMID: 20140794
Related citation

A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme.

Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, Lees S, Stadler J, Crook A, Nunn A, HAYES R, McCormack S.
PLoS One 2010; 5: e11600.
PMID: 20657778
Related citation

Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model.

Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, Lees S, Stadler J, Nunn A, Crook A, HAYES R, McCormack S.
PLoS One 2010; 5: e11632.
PMID: 20657774
Related citation

The last decade of microbicide clinical trials in Africa: from hypothesis to facts.

Ramjee G, Kamali A, McCormack S.
AIDS 2010; 24 (suppl 4): S40-S49.
PMID: 21042052
Related citation

Behavioural interventions to reduce HIV risk: what works?

Ross DA.
AIDS 2010; 24 (suppl 4): S4-S14.
PMID: 21042051
Related citation

Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial.

Tanton C, Weiss HA, Rusizoka M, LeGoff J, Changalucha J, Baisley K, Mugeye K, Everett D, Belec L, Clayton TC, Ross DA, HAYES RJ, Watson-Jones D.
Journal of Infectious Diseases 2010; 201: 1285-1297.
PMID: 20235836
Related citation

Microbicides Development Programme. Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Vallely A, Hambleton IR, Kasindi S, Knight L, Francis SC, Chirwa T, Everett D, Shagi C, Cook C, Barberousse C, Watson-Jones D, Changalucha J, Ross D, Hayes RJ;
PLoS One. 2010 May 14;5(5):e10661.
PMID: 20498833
Related citation

Microbicides Development Programme (MDP). How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.

Vallely A, Lees S, Shagi C, Kasindi S, Soteli S, Kavit N, Vallely L, McCormack S, Pool R, Hayes RJ;
BMC Med Ethics. 2010 Jun 13;11:10.
PMID: 20540803
Related citation